Bridgeway Capital Management’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-56,900
| Closed | -$23.9K | – | 1465 |
|
2022
Q4 | $23.9K | Sell |
56,900
-25,000
| -31% | -$10.5K | ﹤0.01% | 1333 |
|
2022
Q3 | $82K | Hold |
81,900
| – | – | ﹤0.01% | 1309 |
|
2022
Q2 | $89K | Hold |
81,900
| – | – | ﹤0.01% | 1241 |
|
2022
Q1 | $326K | Buy |
81,900
+3,900
| +5% | +$15.5K | 0.01% | 1049 |
|
2021
Q4 | $664K | Buy |
78,000
+25,000
| +47% | +$213K | 0.01% | 908 |
|
2021
Q3 | $601K | Buy |
53,000
+21,038
| +66% | +$239K | 0.01% | 984 |
|
2021
Q2 | $326K | Sell |
31,962
-3,038
| -9% | -$31K | 0.01% | 1192 |
|
2021
Q1 | $382K | Buy |
+35,000
| New | +$382K | 0.01% | 1172 |
|